HEADER HYDROLASE 31-AUG-11 3ZZC TITLE CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A AND N126Y) OF TITLE 2 COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER TITLE 3 INHIBITOR 83 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C PROTEINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: POLYPROTEIN 3BCD; COMPND 5 EC: 3.4.22.28; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN COXSACKIEVIRUS; SOURCE 3 ORGANISM_TAXID: 12072; SOURCE 4 STRAIN: B3; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)GOLD; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET23A; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET23A-COX KEYWDS HYDROLASE, PICORNAVIRIDAE, BETA-UNSATURATED ETHYL ESTER INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.TAN,K.ANAND,J.R.MESTERS,R.HILGENFELD REVDAT 2 08-MAY-19 3ZZC 1 REMARK LINK REVDAT 1 19-SEP-12 3ZZC 0 JRNL AUTH J.TAN,K.ANAND,J.R.MESTERS,R.HILGENFELD JRNL TITL PEPTIDIC ALPHA, BETA-UNSATURATED ETHYL ESTERS AS INHIBITORS JRNL TITL 2 OF THE 3C PROTEASE OF COXSACKIE VIRUS B3: CRYSTAL JRNL TITL 3 STRUCTURES, ANTIVIRAL ACTIVITIES, AND RESISTANCE MUTATIONS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 9886 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 499 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 705 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.87 REMARK 3 BIN R VALUE (WORKING SET) : 0.1910 REMARK 3 BIN FREE R VALUE SET COUNT : 40 REMARK 3 BIN FREE R VALUE : 0.2590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1400 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 47 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.08000 REMARK 3 B22 (A**2) : -0.06000 REMARK 3 B33 (A**2) : -0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.258 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.222 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.142 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.249 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1491 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2010 ; 1.918 ; 2.002 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 181 ; 7.588 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 64 ;35.516 ;23.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 251 ;17.378 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;19.218 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 216 ; 0.128 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1130 ; 0.012 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 890 ; 1.181 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1425 ; 2.163 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 601 ; 3.124 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 584 ; 4.876 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 3ZZC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-AUG-11. REMARK 100 THE DEPOSITION ID IS D_1290049408. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10411 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 34.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 12.10 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 12.30 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: CRYSTAL STRUCTURE OF COXSACKIEVIURS B3 3C PROTEASE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL PH 8.5, 0.2 M REMARK 280 MAGNESIUM CHLORIDE, AND 22% PEG 4000; SITTING DROP, VAPOR REMARK 280 DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.79500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.79500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.88000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 34.67000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.88000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 34.67000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 37.79500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.88000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 34.67000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 37.79500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.88000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 34.67000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -37.79500 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, THR 81 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 139 TO TYR REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 181 REMARK 465 GLU A 182 REMARK 465 GLN A 183 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 75 CA - CB - CG ANGL. DEV. = 15.5 DEGREES REMARK 500 PRO A 141 C - N - CD ANGL. DEV. = -14.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 32 -125.75 55.89 REMARK 500 LYS A 42 61.62 38.43 REMARK 500 ASP A 51 2.05 86.03 REMARK 500 PHE A 109 78.33 -118.64 REMARK 500 PHE A 140 83.72 93.35 REMARK 500 PRO A 141 -105.73 -149.87 REMARK 500 THR A 142 54.49 85.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 141 THR A 142 143.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G83 A 1181 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ZYE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A) OF COXSACKIEVIRUS B3 REMARK 900 RELATED ID: 3ZYD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 REMARK 900 RELATED ID: 3ZZB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED REMARK 900 WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 85 REMARK 900 RELATED ID: 3ZZ6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED REMARK 900 WITH MICHAEL RECEPTOR INHIBITOR 75 REMARK 900 RELATED ID: 3ZZD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A AND N126Y) OF REMARK 900 COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA- UNSATURATED ETHYL REMARK 900 ESTER INHIBITOR 85 REMARK 900 RELATED ID: 3ZZ8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED REMARK 900 WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 82 REMARK 900 RELATED ID: 3ZZ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED REMARK 900 WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 81 REMARK 900 RELATED ID: 3ZZ9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED REMARK 900 WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 83 REMARK 900 RELATED ID: 3ZZ3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (N126Y) OF COXSACKIEVIRUS B3 REMARK 900 RELATED ID: 3ZZ5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED REMARK 900 WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 74 REMARK 900 RELATED ID: 3ZZ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A AND N126Y) OF REMARK 900 COXSACKIEVIRUS B3 REMARK 900 RELATED ID: 3ZZA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED REMARK 900 WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 84 DBREF 3ZZC A 1 183 UNP Q90092 Q90092_9ENTO 14 196 SEQADV 3ZZC ALA A 68 UNP Q90092 THR 81 ENGINEERED MUTATION SEQADV 3ZZC TYR A 126 UNP Q90092 ASN 139 ENGINEERED MUTATION SEQRES 1 A 183 GLY PRO ALA PHE GLU PHE ALA VAL ALA MET MET LYS ARG SEQRES 2 A 183 ASN SER SER THR VAL LYS THR GLU TYR GLY GLU PHE THR SEQRES 3 A 183 MET LEU GLY ILE TYR ASP ARG TRP ALA VAL LEU PRO ARG SEQRES 4 A 183 HIS ALA LYS PRO GLY PRO THR ILE LEU MET ASN ASP GLN SEQRES 5 A 183 GLU VAL GLY VAL LEU ASP ALA LYS GLU LEU VAL ASP LYS SEQRES 6 A 183 ASP GLY ALA ASN LEU GLU LEU THR LEU LEU LYS LEU ASN SEQRES 7 A 183 ARG ASN GLU LYS PHE ARG ASP ILE ARG GLY PHE LEU ALA SEQRES 8 A 183 LYS GLU GLU VAL GLU VAL ASN GLU ALA VAL LEU ALA ILE SEQRES 9 A 183 ASN THR SER LYS PHE PRO ASN MET TYR ILE PRO VAL GLY SEQRES 10 A 183 GLN VAL THR GLU TYR GLY PHE LEU TYR LEU GLY GLY THR SEQRES 11 A 183 PRO THR LYS ARG MET LEU MET TYR ASN PHE PRO THR ARG SEQRES 12 A 183 ALA GLY GLN CYS GLY GLY VAL LEU MET SER THR GLY LYS SEQRES 13 A 183 VAL LEU GLY ILE HIS VAL GLY GLY ASN GLY HIS GLN GLY SEQRES 14 A 183 PHE SER ALA ALA LEU LEU LYS HIS TYR PHE ASN ASP GLU SEQRES 15 A 183 GLN HET G83 A1181 49 HETNAM G83 ETHYL (5S,8S,11R)-8-BENZYL-5-(2-TERT-BUTOXY-2- HETNAM 2 G83 OXOETHYL)-3,6,9-TRIOXO-11-{[(3S)-2-OXOPYRROLIDIN-3- HETNAM 3 G83 YL]METHYL}-1-PHENYL-2-OXA-4,7,10-TRIAZATETRADECAN-14- HETNAM 4 G83 OATE FORMUL 2 G83 C36 H48 N4 O9 FORMUL 3 HOH *47(H2 O) HELIX 1 1 GLY A 1 ASN A 14 1 14 HELIX 2 2 HIS A 40 LYS A 42 5 3 HELIX 3 3 ILE A 86 PHE A 89 5 4 HELIX 4 4 LYS A 176 PHE A 179 5 4 SHEET 1 AA 7 SER A 15 THR A 20 0 SHEET 2 AA 7 GLY A 23 TYR A 31 -1 O GLY A 23 N THR A 20 SHEET 3 AA 7 TRP A 34 PRO A 38 -1 O TRP A 34 N ILE A 30 SHEET 4 AA 7 ASN A 69 LEU A 77 -1 O THR A 73 N LEU A 37 SHEET 5 AA 7 GLN A 52 VAL A 63 -1 N LEU A 57 O LYS A 76 SHEET 6 AA 7 THR A 46 MET A 49 -1 O ILE A 47 N VAL A 54 SHEET 7 AA 7 SER A 15 THR A 20 -1 O LYS A 19 N LEU A 48 SHEET 1 AB 7 MET A 112 PRO A 115 0 SHEET 2 AB 7 VAL A 101 ILE A 104 -1 O LEU A 102 N ILE A 114 SHEET 3 AB 7 VAL A 150 SER A 153 -1 O VAL A 150 N ALA A 103 SHEET 4 AB 7 LYS A 156 ASN A 165 -1 O LYS A 156 N SER A 153 SHEET 5 AB 7 GLN A 168 ALA A 173 -1 O GLN A 168 N ASN A 165 SHEET 6 AB 7 THR A 130 ASN A 139 -1 O ARG A 134 N ALA A 173 SHEET 7 AB 7 VAL A 119 LEU A 127 -1 O THR A 120 N MET A 137 LINK SG CYS A 147 C63 G83 A1181 1555 1555 1.80 SITE 1 AC1 20 ARG A 39 HIS A 40 GLU A 71 ASP A 85 SITE 2 AC1 20 GLY A 88 PHE A 89 LEU A 125 LEU A 127 SITE 3 AC1 20 GLY A 128 THR A 142 ALA A 144 GLY A 145 SITE 4 AC1 20 CYS A 147 HIS A 161 VAL A 162 GLY A 163 SITE 5 AC1 20 GLY A 164 ASN A 165 PHE A 170 HOH A2047 CRYST1 65.760 69.340 75.590 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015207 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014422 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013229 0.00000 MASTER 377 0 1 4 14 0 5 6 0 0 0 15 END